2018-2025 @ DJ Technologies

Disco Secures €36M Seed Funding to Propel Surfaceome Expertise Ahead


To learn the total story, subscribe or check in.

Most cancers

Dec. 12, 2025

By Nuala Moran
No Feedback

Disco Prescription drugs GmbH introduced the ultimate shut of its seed spherical at €36 million (US$42 million), because it shapes up novel targets it has found with its surfaceome platform expertise for formal preclinical improvement.

BioWorld Science Financings Newco information Most cancers Antibody-drug conjugate Bispecific antibody Europe



Supply hyperlink

Posted

in

by

Dinesh

Tags:

, , , , , , ,

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by